International Journal of Trend in Scientific Research and Development: Oncology

IJTSRD is a leading Open Access, Peer-Reviewed International Journal which provides rapid publication of your research articles and aims to promote the theory and practice along with knowledge sharing between researchers, developers, engineers, students, and practitioners working in and around the world in many areas. For any further information, feel free to write us on editor.ijtsrd@gmail.com

Showing posts with label Oncology. Show all posts
Showing posts with label Oncology. Show all posts

Saturday 5 September 2020

Recent Trends in the Study of Herpes Zoster Virus Causing Diseases and Cancer in Human

September 05, 2020 0
Recent Trends in the Study of Herpes Zoster Virus Causing Diseases and Cancer in Human

Varicella zoster virus causes chickenpox and shingles herpes zoster in human. Some of the disease manifestations of herpes zoster are noted as post herpetic neuralgia, optic neuritis and encephalitis including cancer. Though, herpes zoster with the development of cancer in human has a murky relationship, recently it has been proved that herpes zoster develops a variety of cancer in human too. On the contrary, studies have also shown the patients with haematological or solid tumor cancer had a much higher risk of having herpes zoster than those with no cancer detection. The present paper is an attempt to discuss the researches done so far in the field of herpes zoster virus developing diseases and cancer in human. 

by Dr. Mohammad Salim | P. K. Singh | I. P. Prajapati | T. P. Singh "Recent Trends in the Study of Herpes Zoster Virus Causing Diseases and Cancer in Human" 

Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-4 | Issue-6 , October 2020, 

URL: https://www.ijtsrd.com/papers/ijtsrd33308.pdf

Paper Url: https://www.ijtsrd.com/medicine/oncology/33308/recent-trends-in-the-study-of-herpes-zoster-virus-causing-diseases-and-cancer-in-human/dr-mohammad-salim

callforpaperarts, artsjournal, peerreviewedjournal 

Friday 8 May 2020

Highly Conserved Binding Region of ACE2 as Receptor for SARS CoV 2 between Human and Mammals

May 08, 2020 0
Highly Conserved Binding Region of ACE2 as Receptor for SARS CoV 2 between Human and Mammals
In Belgium, case of new coronavirus, severe acute respiratory syndrome coronavirus 2 SARS CoV 2 infection from owner to domestic cat was reported on March 27, 2020. So far, cases of SARS CoV 2 infection from owners to their dogs have been reported. For the first time in the world, the case of SARS CoV 2 transmission from the owner to a domestic cat has been confirmed. A tiger kept at a zoo in New York, USA, was reportedly infected with SRAS CoV 2. It is believed that SRAS CoV 2 has been transmitted to tiger from caretakers infected with SRAS CoV 2. Therefore, we examined the homology of whole molecule and the 5 amino acids residues KGDFR located in the binding region of the angiotensin converting enzyme 2 ACE2 molecule, a receptor for the spike glycoprotein on the virion surface of SRAS CoV 2, between humans, dogs, cats, tiger and other mammals. Although the transmission of human coronavirus to pets or animals is rare, the dangers of transmitting SARS CoV 2 from animals or pets to humans have not been proven. Our findings with Shi's study provide important insights into the animal models for SARS CoV 2 and animal management for COVID 19 control. 

by Takuma Hayashi | Masaki Mandan | Nobuo Yaegashi | Ikuo Konishi ""Highly Conserved Binding Region of ACE2 as Receptor for SARS-CoV-2 between Human and Mammals""

Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-4 | Issue-4 , June 2020,

URL: https://www.ijtsrd.com/papers/ijtsrd30973.pdf

Paper Url :https://www.ijtsrd.com/medicine/oncology/30973/highly-conserved-binding-region-of-ace2-as-receptor-for-sarscov2-between-human-and-mammals/takuma-hayashi

callforpaperpharmacy, pharmacyjournal, internationalpeerreviewedjournal

Wednesday 6 February 2019

Proton Beam Therapy for Prostate Cancer An Overview

February 06, 2019 0
Proton Beam Therapy for Prostate Cancer An Overview
Patients diagnosed with localized prostate cancer have many curative treatment options including several forms of advanced conformal Radiotherapy. Proton radiation is one such radiation treatment modality and, due to its unique physical properties, offers the appealing potential of reduced side effects without sacrificing cancer control. Patients of proton beam therapy PBT for prostate cancer had been continuously growing in number due to its promising characteristics of high dose distribution in the tumor target and a sharp distal fall-off. While theoretically beneficial, its clinical values are still being demonstrated from the increasing number of patients treated with proton therapy, from several dozen proton therapy centers around the world. High equipment and facility costs are often the major obstacle for its wider adoption. The picture will be clearer in coming decade as more and more centers throughout the world avail access to this technique and more data emerges on PBT. 

by Suhag V | Sunita BS | Vats P "Proton Beam Therapy for Prostate Cancer: An Overview" 

Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-3 | Issue-2, February 2019, 

URL: https://www.ijtsrd.com/papers/ijtsrd21439.pdf

Direct Link: https://www.ijtsrd.com/medicine/oncology/21439/proton-beam-therapy-for-prostate-cancer-an-overview/suhag-v

call for paper Oncology, international journal Oncology, ugc approved journals Oncology

Ad